FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $439,541 | -86.1% | 43,562 | -69.2% | 0.04% | -86.2% |
| Q3 2022 | $3,172,315 | -82.4% | 141,558 | -80.5% | 0.28% | -78.5% |
| Q2 2022 | $18,004,801 | +1.8% | 726,586 | +59.3% | 1.28% | -5.7% |
| Q1 2022 | $17,681,407 | +18.6% | 456,059 | +79.0% | 1.36% | +42.6% |
| Q4 2021 | $14,907,763 | -3.6% | 254,790 | -2.3% | 0.95% | -11.3% |
| Q3 2021 | $15,463,247 | -48.6% | 260,895 | -24.7% | 1.07% | -46.4% |
| Q2 2021 | $30,059,456 | +13.3% | 346,347 | +7.6% | 2.00% | +0.5% |
| Q1 2021 | $26,529,112 | -27.0% | 321,760 | -19.5% | 1.99% | -53.2% |
| Q4 2020 | $36,326,444 | +69.9% | 399,499 | -25.3% | 4.26% | -10.3% |
| Q3 2020 | $21,385,389 | +17.3% | 535,036 | +0.7% | 4.75% | +90.2% |
| Q2 2020 | $18,227,462 | +168.7% | 531,258 | +73.9% | 2.50% | +48.1% |
| Q1 2020 | $6,784,822 | -3.9% | 305,485 | -15.3% | 1.69% | +35.4% |
| Q4 2019 | $7,058,038 | +223.1% | 360,656 | +156.4% | 1.25% | +83.8% |
| Q3 2019 | $2,184,388 | -50.6% | 140,656 | -35.4% | 0.68% | -45.2% |
| Q2 2019 | $4,422,477 | -28.1% | 217,856 | -37.8% | 1.24% | -31.0% |
| Q1 2019 | $6,149,693 | +190.5% | 350,011 | +112.1% | 1.79% | +56.5% |
| Q4 2018 | $2,116,950 | – | 165,000 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |